“The Applicant identified the rat and monkey as pharmacologically relevant species for toxicology testing with alirocumab; both species express PCSK9, to which alirocumab binds with high affinity.”
✓ VerifiedFDA pharmacology/toxicology review, p. 9Source ↗
Why that species
Both species express PCSK9 bound with high affinity; human and monkey PCSK9 bound with comparable affinity, rodent PCSK9 with lower affinity
“Alirocumab was shown to bind human and Cynomolgus monkey PCSK 9 with comparable affinity and lower affinity, but in nanomolar range to mouse, hamster, and rat PCSK9.”